Li and colleagues further highlighted the predictive value of decreased DAT in the putamen and striatum, using [99mTC]TRODAT-1 SPECT, in iRBD patients over 5 years with greater DAT deficits in those patients at high risk of progressing to a synucleinopathy [45]. Here, SLC6A3 is linked to synucleinopathy.